Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.       CA14159U3010

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Surperformance© rating of Cardiome Pharma Corp.
Overall rating In sector In country
Trading Rating - - -
Investor Rating
Growth (Revenue)
Valuation - - -
Finances - - -
Profitability
Earnings quality
Business Predictability - - -
PER
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology
CountryTrading RatingInvestor Rating
GILEAD SCIENCES, INC.USA
AMGEN, INC.USA
BIOGEN IDEC INC.USA
CELGENE CORPORATIONUSA
CSL LIMITEDAUSTRALIA
REGENERON PHARMACEUTICALS INCUSA
VERTEX PHARMACEUTICALS INCORPORATEDUSA
LIFE TECHNOLOGIES CORP.USA
ACTELION LTDSwitzerland
ONYX PHARMACEUTICALS, INC.USA
PHARMACYCLICS, INC.USA
QIAGEN NVUSA
SEATTLE GENETICS, INC.USA
COVANCE INC.USA
ALKERMES PLCUSA
BEIJING SL PHARMACEUTICAL CO., LTD.CHINA
LONZA GROUP AGSwitzerland
MEDIVATION INCUSA
UNITED THERAPEUTICS CORPORATIONUSA
JAZZ PHARMACEUTICALS PLCUSA
INCYTE CORPORATIONUSA
EUROFINS SCIENTIFICFrance
CELLTRION, INC.KOREA, REPUBLIC OF
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTDCHINA
-
PAREXEL INTERNATIONAL CORPORATIONUSA
Sector Biotechnology
Data source :
© 2013 Thomson Reuters		 Ratings :
© 2013 Surperformance
Advertisement
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.